media – Page 490 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Brain U Online Delays Dementia

The subscription-based consumer-friendly service named Brain U Online provides cognitive tasks with exercise to delay the progression of dementia by 2.5 years and reduce its negative effect by 45%.
- Source: MobiHealthNews
- 736
- June 28, 2018
Dementia mHealth New Approvals
Celgene Collaboration with Skyhawk for Drug Discovery against Neurological Diseases

To develop small molecules which can target RNA mis-splicing in neurological diseases, Celgene is launching a $60 million collaboration with Skyhawk Therapeutics. Celgene received the option to develop up to five drug molecules for correcting neurological diseases such as Huntington’s disease, amyotrophic lateral sclerosis etc. The $60 million payment includes milestones, license fees and royalties.
- Source: FierceBiotech
- 675
- June 28, 2018
cancer Company Insight neurological
Dementia Discovery Fund, Surpassed Funding Target

The DDF initially aimed to raise £130 million with committed investments from GlaxoSmithKline, Biogen, Eli Lilly, Pfizer and Takeda, Johnson & Johnson, as well as the U.K. government’s Department of Health and the nonprofit Alzheimer’s Research UK.
- Source: FierceBiotech
- 611
- June 27, 2018
Company Insight Dementia funding
South Korean KT Crop to Provide Digital Healthcare System in Russia

KT Corporation, the largest leading telephone company on South Korea, showcased a telemedicine system at its launching ceremony of its global pilot project last week, that connects Central Clinical Hospital No.1 of Moscow, with regional hospitals in Tula and Yaroslavl, 200 km and 300 km away for the capital.
- Source: Cision
- 663
- June 27, 2018
Company Insight digital health Telemedicine
New UltraSound System Launched by Siemens Healthneers

German Based Medical Tech Company Siemens Healthineers recently launched “Acuson Sequoia” a new imaging ultrasound system which enables imaging of different sized patients with unchanging clarity. The newly developed devices provide advanced high-powered architecture Deep Abdominal Transducer (DAX) and other improvements to elastography and contrast-enhanced ultrasound. To enable better diagnosis the device can produce penetration of up to 40cm to offer high-resolution imaging.
- Source: Verdict Medical Devices
- 599
- June 27, 2018
Company Insight imaging medtech Siemens
Johnson & Johnson Innovation Opens JLABS @ NYC In SoHo

Johnson & Johnson Innovation in collaboration with New York State and the New York Genome Center launched JLABS in New York Genome Center, New York City. The size of the new facility is 30,000 Sq. ft. The new facility will enable 30 biotech, medical device, pharmaceutical, consumer and health tech companies with 26 resident companies, including the four winners of the JLABS at QuickFire Challenge.
- Source: Pharmaceutical Online
- 742
- June 27, 2018
Company Insight Johnson & Johnson
Food Allergen Detector at $40

This keychain-sized portable allergen detector is called an Integrated Exogenous Antigen Testing System (IEAT). By placing a drop or a bit of food on a single use slide namely an ‘antigen extraction device’, it can detect the allergen and its quantity within 10 minutes by performing necessary chemical deconstruction.
- Source: mHealthSpot
- 872
- June 27, 2018
Allergies digital health mHealth Researches
Predict Your Diabetes Risk Levels by Checking Your Partner’s BMI

According to the WHO statistical report, around 1.5 million deaths are caused due to diabetes worldwide. With these statistics in mind, a research team from the University of Copenhagen and Aarhus University in Denmark conducted research on diabetes patients.
- Source: India Times
- 690
- June 27, 2018
BMI diabetes Researches
3 Homemade Tonics Against Autoimmune Diseases

We have listed three scientifically validated drinks which help to fight against autoimmune disorders.
- Source: Healthline
- 579
- June 27, 2018
autoimmune health tips Researches
FDA Approval for Eversense – Continuous Glucose Monitoring System

The FDA has finally approved to market the implantable continuous glucose monitoring system named Eversense, from Senseonics, in the United States.
- Source: MobiHealthNews
- 964
- June 27, 2018
diabetes digital health mHealth New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.